Related Experiment Video
Updated: Mar 18, 2026
06:17
A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
12.7K
Trifluoroethanol modulates α-synuclein amyloid-like aggregate formation, stability and dissolution
Maria Giovanna Di Carlo1, Valeria Vetri2, Gianpiero Buscarino1
1Dipartimento di Fisica e Chimica, Università degli Studi di Palermo, Viale delle Scienze, Edificio 18, 90128 Palermo, Italy.
Biophysical Chemistry
|July 4, 2016
Summary
Alpha-Synuclein (αSN) aggregation is linked to Parkinson's disease. This study reveals how solution conditions, like trifluoroethanol concentration, affect αSN aggregate stability and disassembly, offering insights into toxic species formation.
Area of Science:
- Biochemistry
- Neuroscience
- Biophysics
Background:
- Protein aggregation into amyloid fibrils is implicated in age-related diseases.
- Oligomeric aggregates, formed from amyloid disassembly, are key toxic species.
- Alpha-Synuclein (αSN) aggregation is central to Parkinson's disease pathogenesis.
Purpose of the Study:
- To investigate the supramolecular assembly, stability, and disassembly pathways of alpha-Synuclein (αSN).
- To understand how environmental conditions influence αSN aggregate structures.
- To explore mechanisms underlying αSN oligomer clustering and dissolution in cellular contexts.
Main Methods:
- Spectroscopic techniques
- Two-photon microscopy
- Small-angle X-ray scattering (SAXS)
- Atomic force microscopy (AFM)
Main Results:
- Amyloid-like aggregate formation of αSN induced at high temperature with trifluoroethanol (TFE).
- Varying TFE concentration triggers sudden disassembly or reorganization into higher-order structures.
- Demonstrated environmental control over αSN aggregate stability and structural dynamics.
Conclusions:
- Solution conditions significantly impact αSN aggregate stability and disassembly.
- Environmental factors can drive the formation and transformation of toxic αSN species.
- Findings contribute to understanding αSN oligomer dynamics relevant to neurodegenerative diseases.
